Sanara MedTech Other Share Holders Equity 2014-2024 | SMTI
Sanara MedTech Annual Other Share Holders Equity (Millions of US $) |
|
---|---|
2023 | $ |
2022 | $ |
2021 | $ |
2020 | $ |
2019 | $ |
2018 | $ |
2017 | $ |
2016 | $ |
2015 | $ |
2014 | $ |
2013 | $ |
Sanara MedTech Quarterly Other Share Holders Equity (Millions of US $) |
|
---|---|
2024-06-30 | |
2024-03-31 | |
2023-12-31 | |
2023-09-30 | |
2023-06-30 | |
2023-03-31 | |
2022-12-31 | |
2022-09-30 | |
2022-06-30 | |
2022-03-31 | |
2021-12-31 | |
2021-09-30 | |
2021-06-30 | |
2021-03-31 | |
2020-12-31 | |
2020-09-30 | |
2020-06-30 | |
2020-03-31 | |
2019-12-31 | |
2019-09-30 | |
2019-06-30 | |
2019-03-31 | |
2018-12-31 | |
2018-09-30 | |
2018-06-30 | |
2018-03-31 | |
2017-12-31 | |
2017-09-30 | $0 |
2017-06-30 | $0 |
2017-03-31 | $0 |
2016-12-31 | $0 |
2016-09-30 | |
2016-06-30 | |
2016-03-31 | |
2015-12-31 | $0 |
2015-09-30 | |
2015-06-30 | |
2015-03-31 | |
2014-12-31 | $0 |
2014-09-30 | |
2014-06-30 | |
2014-03-31 | |
2013-12-31 | $0 |
2013-09-30 | |
2013-06-30 | |
2013-03-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.293B | $0.065B |
Wound Management Technologies Inc. develops and markets wound care products. It develops, markets and distributes biotechnology products to physicians, hospitals and clinics. The Company markets collagen-based products for the treatment of pressure ulcers, diabetic ulcers, surgical wounds, ulcers due to arterial insufficiency, traumatic wounds, first and second degree burns and superficial wounds. It sells and distributes CellerateRX(R) Surgical Activated Collagen(R) Adjuvant as well as HemaQuell(R) Resorbable Bone Hemostat. Wound Management Technologies Inc. is based in Fort Worth, Texas. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $204.059B | 26.03 |
Stryker (SYK) | United States | $139.868B | 31.52 |
Boston Scientific (BSX) | United States | $124.863B | 35.90 |
Medtronic (MDT) | Ireland | $114.537B | 17.04 |
EssilorLuxottica (ESLOY) | France | $110.799B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $45.365B | 0.00 |
Haleon (HLN) | United Kingdom | $44.180B | 28.71 |
GE HealthCare Technologies (GEHC) | United States | $39.743B | 20.61 |
ResMed (RMD) | United States | $35.761B | 29.39 |
Terumo (TRUMY) | Japan | $28.532B | 40.29 |
Koninklijke Philips (PHG) | Netherlands | $25.454B | 19.48 |
Zimmer Biomet Holdings (ZBH) | United States | $21.582B | 13.74 |
Baxter (BAX) | United States | $18.264B | 12.39 |
Insulet (PODD) | United States | $16.648B | 70.04 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.052B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $10.282B | 35.10 |
BellRing Brands (BRBR) | United States | $8.726B | 36.90 |
Demant (WILYY) | Denmark | $8.351B | 0.00 |
Lantheus Holdings (LNTH) | United States | $8.016B | 19.24 |
ICU Medical (ICUI) | United States | $4.201B | 40.09 |
TG Therapeutics (TGTX) | United States | $3.771B | 0.00 |
Haemonetics (HAE) | United States | $3.763B | 18.61 |
Envista Holdings (NVST) | United States | $3.662B | 27.28 |
Prestige Consumer Healthcare (PBH) | United States | $3.657B | 18.22 |
Perrigo (PRGO) | Ireland | $3.466B | 10.95 |
Neogen (NEOG) | United States | $3.127B | 36.08 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
GN Store Nord (GNNDY) | Denmark | $2.988B | 18.00 |
QuidelOrtho (QDEL) | United States | $2.628B | 16.56 |
Agios Pharmaceuticals (AGIO) | United States | $2.557B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.260B | 38.14 |
LeMaitre Vascular (LMAT) | United States | $2.165B | 52.65 |
Curaleaf Holdings (CURLF) | Canada | $2.023B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.960B | 0.00 |
Warby Parker (WRBY) | United States | $1.769B | 0.00 |
AtriCure (ATRC) | United States | $1.641B | 0.00 |
InMode (INMD) | Israel | $1.460B | 8.78 |
AdaptHealth (AHCO) | United States | $1.365B | 9.85 |
Verano Holdings (VRNOF) | United States | $1.231B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.179B | 0.00 |
Evolus (EOLS) | United States | $1.036B | 0.00 |
Owens & Minor (OMI) | United States | $0.925B | 7.23 |
National Vision Holdings (EYE) | United States | $0.915B | 29.08 |
Phibro Animal Health (PAHC) | United States | $0.906B | 18.80 |
CeriBell (CBLL) | United States | $0.893B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.844B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.747B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.542B | 16.36 |
Surmodics (SRDX) | United States | $0.536B | 113.85 |
Quanterix (QTRX) | United States | $0.532B | 0.00 |
Canopy Growth (CGC) | Canada | $0.515B | 0.00 |
Valneva SE (VALN) | France | $0.475B | 0.00 |
ZimVie (ZIMV) | United States | $0.398B | 33.56 |
Viemed Healthcare (VMD) | United States | $0.331B | 35.54 |
Aurora Cannabis (ACB) | Canada | $0.328B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.315B | 8.12 |
TerrAscend (TSNDF) | Canada | $0.309B | 0.00 |
Jin Medical (ZJYL) | China | $0.308B | 0.00 |
Cerus (CERS) | United States | $0.290B | 0.00 |
Biote (BTMD) | United States | $0.280B | 12.93 |
Ayr Wellness (AYRWF) | United States | $0.279B | 0.00 |
Zynex (ZYXI) | United States | $0.255B | 53.33 |
Omeros (OMER) | United States | $0.246B | 0.00 |
High Tide (HITI) | Canada | $0.234B | 97.00 |
MacroGenics (MGNX) | United States | $0.232B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.225B | 15.14 |
Organigram Holdings (OGI) | Canada | $0.195B | 0.00 |
Brainsway (BWAY) | Israel | $0.172B | 206.40 |
FitLife Brands (FTLF) | United States | $0.145B | 19.54 |
Rockwell Medical (RMTI) | United States | $0.121B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.117B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.113B | 0.00 |
Veru (VERU) | United States | $0.107B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 23.90 |
Fonar (FONR) | United States | $0.092B | 9.51 |
Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.082B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.079B | 0.00 |
InterCure (INCR) | Israel | $0.079B | 0.00 |
Modular Medical (MODD) | United States | $0.073B | 0.00 |
Safety Shot (SHOT) | United States | $0.065B | 0.00 |
Sanuwave Health (SNWVD) | United States | $0.064B | 1.63 |
MariMed (MRMD) | United States | $0.062B | 0.00 |
Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.045B | 0.00 |
Exagen (XGN) | United States | $0.043B | 0.00 |
Apyx Medical (APYX) | United States | $0.040B | 0.00 |
ImmuCell (ICCC) | United States | $0.028B | 0.00 |
Flora Growth (FLGC) | United States | $0.020B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
Nephros (NEPH) | United States | $0.015B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
GlucoTrack (GCTK) | United States | $0.006B | 0.00 |
Agape ATP (ATPC) | $0.006B | 0.00 | |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
Senestech (SNES) | United States | $0.001B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 17.87 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |